WHO ICTRP trial
A study to observe the effect of a drug Atosiban in patients undergoing embryo…
CTRI/2017/09/009593 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/09/009593 |
|---|---|
| Public title | A study to observe the effect of a drug Atosiban in patients undergoing embryo transfer procedure for in vitro fertilization |
| Scientific title | Effect of Oxytocin receptor antagonist in Embryo transfer recipients |
| Primary sponsor | Infertility Department |
| Secondary sponsors | Ajanta Hospital IVF Centre |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Primary and Secondary Infertility |
| Interventions | Intervention1: Atosiban: Atosiban is an oxytocin receptor antagonist.0.9 ml of 6.75mg/ml Atosiban injection is given as an intervenous bolus 30 minutes prior to embryo transfer. An infusion of Atosiban in normal saline is started… |
| Registration date | Jan 9, 2017 |
| Target size | 200 |
| Secondary IDs | U1111-1189-9587 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: